Canon Medical Launches CT Solution to Quickly and Safely Image Patients With Viral Infectious Diseases

Deployable CT Solutions + Rapid Decontamination Can Help Hospitals Isolate Patients and Decontaminate the System for More Effective Care

What To Know

  • The deployable system includes the Aquilion™ Prime SP CT system in a modular or mobile footprint with a rapid decontamination tool, to help isolate and decontaminate the CT for rapid, safe imaging.
  • Now available in a modular or mobile setup for easy deployment, the system can be isolated from other facility staff and patients, providing a safer environment for imaging patients suspected to have infectious diseases.

In today’s challenging healthcare environment, radiology departments are often faced with the difficult decision of how to safely image patients who are suspected of being positive with infectious disease.

To help hospitals and institutions effectively utilize CT with these conditions, Canon Medical Systems USA, Inc. introduces a deployable CT with a rapid decontamination solution. The deployable system includes the Aquilion™ Prime SP CT system in a modular or mobile footprint with a rapid decontamination tool, to help isolate and decontaminate the CT for rapid, safe imaging.

The Aquilion Prime SP CT system offers complete clinical capability, with advanced imaging technology from Canon Medical’s high-end CT systems with the right balance between image quality and lower dose for every patient. The system can generate 160 unique slices per rotation with 0.35-second scanning, reducing time required to perform studies for compromised patients, and also increase throughput. With a 78-cm aperture gantry and a 660-pound patient-weight-capacity couch, the system is ideal for use in an emergency setting. The Aquilion Prime SP is now also available with Advanced Intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), enabling clinicians to enhance diagnostic confidence at low doses. Now available in a modular or mobile setup for easy deployment, the system can be isolated from other facility staff and patients, providing a safer environment for imaging patients suspected to have infectious diseases.

The decontamination system is an automated UV-C technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. The system incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow. The decontamination system is available for the new deployable CT solutions, as well as existing fixed imaging suites.

“Imaging infectious disease patients is not a new phenomenon for medical providers. But our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy